Basal cell carcinoma

Related records

Broader conditions (10)

• Basal cell neoplasm
• Cancer
• Cancer or benign tumor
• Carcinoma
• Disease
• Disease by etiologic mechanism
• Epithelial neoplasm
• Human disease
• Neoplasm
• Neoplastic disease or syndrome

Narrower conditions (27)

• Adamantinoid basal cell epithelioma
• Anal margin basal cell carcinoma
• Basosquamous carcinoma
• Cervical adenoid basal carcinoma
• External ear basal cell carcinoma
• Follicular atrophoderma-basal cell carcinoma
• Follicular basal cell carcinoma
• Infundibulocystic basal cell carcinoma
• Metatypical basal cell carcinoma
• Micronodular basal cell carcinoma
• Morpheaform basal cell carcinoma
• Nodular basal cell carcinoma
• Penis basal cell carcinoma
• Salivary gland basal cell adenocarcinoma
• Sarcomatoid basal cell carcinoma
• Scrotum basal cell carcinoma
• Sebaceous basal cell carcinoma
• Signet ring basal cell carcinoma
• Skin adenoid basal cell carcinoma
• Skin basal cell carcinoma

Trials (370)

• (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)
• A Beta-only IL-2 ImmunoTherapY Study
• A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
• A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
• A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
• A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
• A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
• A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
• A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
• A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
• A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
• A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base
• A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma
• A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma
• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma
• A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
• A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists
• A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma
• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Approved drugs (6)

• Aminolevulinic acid hydrochloride
• Cemiplimab
• Fluorouracil
• Imiquimod
• Sonidegib phosphate
• Vismodegib

Drugs in development (33)

• Aminolevulinic acid Phase 2
• Ascorbic acid Early phase 1
• BMS-833923 Phase 1
• Calcitriol Phase 2
• Calcium chloride Phase 3
• Cisplatin Phase 1
• Diclofenac Phase 2
• Hydrogen peroxide Phase 2
• Ingenol mebutate Phase 2
• Ipilimumab Phase 2
• Irinotecan hydrochloride Phase 1
• Itraconazole Phase 2
• LEQ506 Phase 1
• Methyl aminolevulinate Phase 3
• Niacinamide Phase 2
• Nivolumab Phase 2
• Patidegib Phase 2
• Patidegib hydrochloride Phase 1
• Programmed cell death 1 ligand 1 Phase 2
• Relatlimab Phase 2

Other linked drugs (1)

• Doxorubicin